疼痛管理機器の市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測 2025-2032年

疼痛管理機器市場規模は2023年に59億6,000万米ドルと評価され、2024年の65億2,000万米ドルから2032年には133億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.4％で成長する見通しです。

疼痛管理機器市場は、慢性疼痛疾患の有病率の上昇と継続的な技術革新に牽引され、急速な成長を遂げています。慢性疼痛は世界中で数百万人に影響を及ぼし、ヘルスケアの重要な課題として浮上しており、効果的な管理ソリューションの必要性が高まっています。電気刺激、高周波アブレーション、髄腔内ドラッグデリバリーシステムなど様々な方法が、従来の疼痛緩和アプローチに代わる実行可能な非薬物療法として認識されつつあります。関節リウマチやがんなどの疾患は、持続的な疼痛緩和の選択肢に対する需要を促進しています。潜在的な合併症などのリスクが市場拡大の課題となっている一方で、技術の進歩によりこれらの機器の有効性とアクセシビリティが向上しており、患者と医療従事者の両方がその価値を認めているため、この分野の継続的な成長が確実なものとなっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢

疼痛管理機器市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 電気刺激装置
• 高周波アブレーション装置
• 鎮痛剤注入ポンプ
• 神経刺激装置
• その他

疼痛管理機器市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 神経障害性疼痛
• がんの痛み
• 顔面痛と片頭痛
• 筋骨格系の痛み
• その他

疼痛管理機器市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• 在宅ケア
• その他

疼痛管理機器市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Medtronic（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Stryker Corporation（USA）
• Becton, Dickinson and Company（USA）
• Baxter International Inc.（USA）
• B. Braun SE（Germany）
• Omron Corporation（Japan）
• Avanos Medical, Inc.（USA）
• Teleflex Incorporated（USA）
• ICU Medical, Inc.（USA）
• Nipro Corporation（Japan）
• Moog Inc.（USA）
• Atricure, Inc.（USA）
• Micrel Medical Devices SA（Greece）
• Zynex, Inc.（USA）
• Enovis Corporation（USA）
• Stimwave Technologies（USA）
• SPR Therapeutics（USA）

結論と提言

Pain Management Devices Market size was valued at USD 5.96 billion in 2023 and is poised to grow from USD 6.52 billion in 2024 to USD 13.38 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The pain management devices market is experiencing rapid growth, driven by the rising prevalence of chronic pain conditions and ongoing technological innovations. Chronic pain, which impacts millions worldwide, has emerged as a significant healthcare challenge, enhancing the need for effective management solutions. Various methods, including electrical stimulation, radiofrequency ablation, and intrathecal drug delivery systems, are increasingly being recognized as viable non-drug alternatives to traditional pain relief approaches. Conditions like rheumatoid arthritis and cancer are propelling demand for lasting pain relief options. While risks such as potential complications pose challenges to market expansion, advancements in technology are enhancing the efficacy and accessibility of these devices, ensuring continued growth in the sector as both patients and healthcare professionals acknowledge their value.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pain Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pain Management Devices Market Segments Analysis

Global Pain Management Devices Market is segmented by Product, Application, End-Use and region. Based on Product, the market is segmented into Electrical Stimulators, Radiofrequency Ablation Devices, Analgesic Infusion Pumps, Neurostimulation Devices and Others. Based on Application, the market is segmented into Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers, Home Healthcare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pain Management Devices Market

The increasing incidence of chronic pain, particularly among the aging population, significantly drives the demand for pain management devices. Chronic pain stems from various conditions, including arthritis, cancer, and postoperative recovery, becoming increasingly prevalent and necessitating effective management solutions. As patients seek long-term pain relief without relying on opioid medications, both individuals and healthcare providers are actively exploring alternative treatment options. This shift towards non-opioid therapies is contributing to the rising adoption of pain management devices, as they offer innovative solutions to address the growing need for effective and sustainable pain relief strategies in patients' everyday lives.

Restraints in the Pain Management Devices Market

A significant challenge facing the pain management devices market is the elevated cost of these products. High-tech solutions, particularly nerve replacement devices and implant systems, often come with prohibitive price tags that can deter many patients from accessing them. The initial purchase costs are just the beginning; ongoing expenses for maintenance, repairs, and potential replacements further restrict accessibility. This issue is particularly pronounced in low to middle-income regions, where healthcare professionals may be forced to explore more affordable pain management alternatives, limiting the overall potential of advanced pain management technologies in these areas.

Market Trends of the Pain Management Devices Market

The Pain Management Devices market is witnessing a significant shift towards non-invasive solutions, driven by both patient preference and healthcare provider recommendations. Technologies such as Transcutaneous Electrical Nerve Stimulation (TENS) and innovative wearable pain management devices are gaining traction for their ability to deliver effective pain relief without the risks associated with surgical procedures or implants. This growing demand is fueled by benefits such as ease of use, a reduced likelihood of complications, and lower costs compared to invasive alternatives. As new non-invasive devices continue to enter the market, the trend is expected to persist, fundamentally reshaping pain management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape

Global Pain Management Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Electrical Stimulators
• Radiofrequency Ablation Devices
• Analgesic Infusion Pumps
• Neurostimulation Devices
• Others

Global Pain Management Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Others

Global Pain Management Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Home Healthcare
• Others

Global Pain Management Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End-Use)
  • US
  • Canada
• Europe (Product, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atricure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micrel Medical Devices SA (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zynex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations